by The demineralized bone matrix market is witnessing significant growth fueled by the rising incidence of orthopedic disorders and dental diseases around the globe. Demineralized bone matrix is derived from human or animal bones and is widely used in orthopedic, dental, and plastic surgery procedures owing to its favorable bone grafting properties
The Global Demineralized Bone Matrix Market is estimated to be valued at US$ 733.13 Mn in 2024 and is expected to exhibit a CAGR of 4.3% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the demineralized bone matrix are Medtronic Plc, Johnson & Johnson (DePuy Synthes), Exactech, Inc., HansBioMed, Xtant Medical, Stryker, Arthrex GmbH, RTI Surgical, Zimmer Biomet., and Straumann.
Growing prevalence of musculoskeletal disorders such as osteoarthritis, coupled with rising sports and road injuries, is driving the demand for bone grafts. Moreover, increasing count of dental restoration procedures owing to the rising expenditure on dental care is propelling the Demineralized Bone Matrix Market growth into emerging nations and improving access to advanced medical technologies are also key factors propelling the global demineralized bone matrix market. Major market players are focusing on geographical expansions to boost product availability and uptake in high-growth markets.
Market key trends
It acts as an osteoconductive scaffold that promotes bone formation and healing at the defect site.Demineralized bone matrix provides critical growth factors, collagen-based matrices, and other proteins that aid in new bone development. The desirable physical and biological characteristics of demineralized bone matrix products have increased their adoption in dental bone regeneration, spinal fusion, trauma fixations, and various reconstructive applications.
Demineralized Bone Matrix Market Challenges and Opportunities include addressing the increasing demand for bone grafts driven by rising sports and road injuries and a higher number of dental restoration procedures due to increased expenditure on dental care. Geographic expansion into emerging nations and improving access to advanced medical technologies are also key factors propelling market growth. Major market players are focusing on geographical expansions to enhance product availability and uptake in high-growth markets.
Porter’s Analysis
Threat of new entrants: Low capital requirements and no major economies of scale make entry relatively easy.
Bargaining power of buyers: The fragmented market with many buyers minimizes individual buyer power.
Bargaining power of suppliers: A few large suppliers exist for the raw materials, giving them some bargaining leverage.
Threat of new substitutes: Substitute bone graft materials can threaten market share.
Competitive rivalry: The market is highly competitive with many companies offering similar products.
Geographical Regions
North America holds the largest share of the demineralized bone matrix market, valued at around US$ 310.8 Mn in 2024 due to technical advancements in reconstruction surgeries and increasing number of sports injuries. Asia Pacific region is expected to grow at the highest CAGR during the forecast period due rising healthcare expenditure along with increasing awareness about bone grafting procedures.
*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile
